Pfizer's Prevnar 13 Meets All Study Endpoints in Two Phase III Trials (PFE)

by Benzinga Staff
May 9, 2011 8:03 AM | 5 seconds read |
Pfizer's Prevnar 13 Meets All Study Endpoints in Two Phase III Trials PFE
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDAHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!